(Q45959644)

18 December 2017

title

The pharmacogenetics of lithium response depends upon clinical co-morbidity. (English)

1 reference

18 December 2017

author name string

Troy Bremer

1 reference

18 December 2017

Cornelius Diamond

1 reference

18 December 2017

Rebecca McKinney

1 reference

18 December 2017

Tatyana Shehktman

1 reference

18 December 2017

Thomas B Barrett

1 reference

18 December 2017

Chris Herold

1 reference

18 December 2017

John R Kelsoe

1 reference

18 December 2017

publication date

1 January 2007

1 reference

18 December 2017

Molecular Diagnosis and Therapy

published in

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

161-170

1 reference

18 December 2017

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Refractoriness induced by lithium discontinuation despite adequate serum lithium levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Clinical Factors in Lithium Carbonate Prophylaxis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Pharmacogenetics and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Chronic lithium administration alters a prominent PKC substrate in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Inhibitors of inositol monophosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Trimming, weighting, and grouping SNPs in human case-control association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256238

The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain

21 January 2018

1 reference

12 December 2020

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs

1 reference

12 December 2020

Scope of ophthalmic plastic and reconstructive surgery

1 reference

12 December 2020

A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment

1 reference

12 December 2020

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

12 December 2020

How effective is long-term lithium prophylaxis?

1 reference

12 December 2020

Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness

1 reference

12 December 2020

A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22.

1 reference

12 December 2020

Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder

1 reference

12 December 2020

Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study

1 reference

12 December 2020

Relationship between the effectiveness of lithium therapy and family history

1 reference

12 December 2020

The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH.

1 reference

12 December 2020

Mania. Diagnosis, state measurement and prediction of treatment response

1 reference

12 December 2020

Lithium response and genetics of affective disorders

1 reference

12 December 2020

Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium

1 reference

12 December 2020

Properties of inositol polyphosphate 1-phosphatase

1 reference

12 December 2020

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256238

1 reference

18 December 2017

Dimensions Publication ID

1031419422

0 references

1 reference

18 December 2017